Stockreport

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient [Yahoo! Fina...

Shuttle Pharmaceuticals Holdings, Inc.  (SHPH) 
PDF development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announced today first patient e [Read more]